# Specification Quality Checklist: DEV-349 Ollama provisioning and isolated real-model proof

**Purpose**: Validate specification completeness and quality before planning and Gate 1
**Created**: 2026-10-21
**Feature**: [spec.md](../spec.md)

## Content Quality

- [x] No unnecessary implementation detail beyond the frozen ticket scope (Compose services, init script, opt-in IntegrationTests, CI filter, and docs are the ticket subject; edit order lives in `plan.md` and `tasks.md`)
- [x] Focused on operator and maintainer value (model-ready Compose + isolated real-model proof + default-suite safety)
- [x] Written so a reviewer can test each scenario without inventing a ruling
- [x] All mandatory sections completed

## Requirement Completeness

- [x] No [NEEDS CLARIFICATION] markers remain
- [x] Requirements are testable and unambiguous
- [x] Success criteria are measurable
- [x] Success criteria state ticket outcomes (model-aware healthy Compose, restart retention, controlled failure, default isolation, opt-in 384-dim proof) without adding an out-of-scope stack
- [x] All acceptance scenarios are defined
- [x] Edge cases are identified (Epic 7 sequencing per PRODUCT.md:17, predecessor readiness, no dimension manufacture, no Validate change, no health cycle, no volume reuse)
- [x] Scope is clearly bounded (FR-015; Frozen scope)
- [x] Dependencies and assumptions identified (ASSUMPTIONS taste names; Q1–Q8 are rulings; Phase B recon facts explicitly deferred)

## Feature Readiness

- [x] Outcome story FRs map to user stories and success criteria; supporting documentation FRs (FR-005, FR-011) and negative-constraint / boundary FRs (FR-013, FR-016) are covered by explicit task and boundary checks rather than invented product SCs. All numbered requirements remain mapped to tasks.
- [x] User scenarios cover primary flows (US1 provisioning, US2 real-model proof, US3 isolation mapping ticket AC)
- [x] Feature meets measurable outcomes defined in Success Criteria
- [x] No owner checkbox is opened by this draft
- [x] L clarify session recorded; no critical open ambiguities (grill Q1–Q8 closed; Plan-challenge L1/L2 amendment recorded)
- [x] Proposed ADR path unchanged and proposed through Phase A and Gate 1; Phase B lifecycle (T001 number, Anvil rename/Accepted, T013 README, T015 verify) authorized; Quill does not edit or number the ADR now

## Notes

- Validation passed on the first pass. No spec section was rewritten to force a check.
- No `needs decision` item. Q1–Q8 are closed in `brief.md`. Exact image digest, CLI mechanics, cleanup numeric budget, and merged DEV-412 registration names are Phase B recon facts, not open product decisions.
- Drafting/analysis correction round 1: PRODUCT Epic 7 sequencing is an explicit Phase B entry check; Compose plus isolated proof is not a sequencing exception. ADR plan hyperlink was incorrectly changed to `../../../` and later reanalysis accepted that path; plan-challenge C1 retracts that verification and restores `../../docs/adr/DEV-349-isolated-ollama-test.md`.
- Plan-challenge correction round 1 of 2: S1–S3, L1–L2, C1–C2 applied per adjudication-DEV-349-plan-round1:19-25 and brief.md:89-97. See DRAFTING_RECEIPT.md plan-challenge correction receipt.
- Key Entities name infrastructure seams only; no new persistence entity.
- Checklist is requirements-quality validation, not runtime proof that Compose or the opt-in test already pass.
